Pharmacy’s Never Ending Story: PBM Reform Act and Medicare Drug Pricing Changes with Doug Hoey, NCPA

Episode notes

Send us Fan Mail Schedule an Rx Assessmen t Subscribe to Master The Margin H.R. 4317, PBM transparency and Medicare drug pricing...The legislative landscape is shifting fast, and if pharmacy owners want a sustainable future, advocacy can’t be optional. So where do things stand and what’s next? In this episode of The Bottom Line Pharmacy Podcast, Scotty Sykes, CPA, CFP®, and Bonnie Bond, CPA, sit down with B. Douglas Hoey, CEO of the NCPA, to discuss: - What the PBM Reform Act means for pharmacy reimbursement - How Medicare drug pricing changes will impact your margins - Why advocacy doesn’t stop after a legislative win And more! More About Our Guest: Douglas Hoey is the Chief Executive Officer of the National Community Pharmacists Association. NCPA represents the owners of nearly 20,000 pharmacy small businesses who’s pharmacists provide prescription dispensing services and help fill primary care gaps. The majority of these pharmacies are located in areas the CDC ranks as “high” or “very high” on the Socially Vulnerable Index. Consumers consistently rank community pharmacies as the top-rated pharmacies in the country.